A grassroots organization that formed with the goal of recalibrating cancer care around patient needs issued guidance ...

In 2025, newly-designed clinical trials for people with cancer are providing new options and hope for patients and their ...

Jonathan Kimmelman, PhD, has published multiple research papers and gotten into an inordinate number of debates about the clinical value of phase 1 trials.“I’ve argued for a long time that for phase 1 ...

A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic colorectal cancer that have stopped ...

The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...

In a Phase 1b/2a trial for lymphoma and cytokine release syndrome, the first group's dose-limiting toxicity observation ...

Ferring Pharmaceuticals announced strong performance results for 2024, with one part of the announcement standing out as ...

Gilead Sciences has reported positive topline data from the randomised Phase III ASCENT-04/KEYNOTE-D19 trial of Trodelvy ...

Full abstracts will be released by ASCO on Thursday, May 22, 2025, at 5:00 PM ET. Details from the presentations will be ...

The full abstract will be available on the ASCO® website on May 22, 2025, at 5:00 p.m. ET.